Press Release
Wall Street Funded, the Prop Firm Led by Traders, Reaches 25,000 Users and Prepares the Launch of Its Own Broker
The financial sector is undergoing a significant transformation, and Wall Street Funded, an emerging funding firm founded in early 2024, is determined to lead the way. With over 25,000 traders relying on its services and sustained growth since its inception, the company has already surpassed $1.2 Million in payouts to its clients—a milestone that establishes it as a trustworthy option in a competitive market.
A Unique approach led by expert traders
Unlike other companies in the sector, Wall Street Funded stands out for being managed by professionals with over a decade of trading experience. The company was founded by Iñaki Martínez and Albert Suriol, both spanish traders, to address gaps observed in the market, where most funding companies were run by marketing specialists rather than trading or finance experts. This approach allows them to offer a more robust and tailored proposition that meets the actual needs of traders.
This vision and expertise are reflected in the company’s support team. Their staff consists of highly skilled trading specialists equipped to quickly and effectively address client needs. Their proximity-focused model enables personalized attention, which sets them apart in the market. Moreover, the company has concentrated its efforts on addressing sector shortcomings, particularly in areas like understanding trading dynamics and risk management—two key aspects that underpin its value proposition.
Recognitions and achievements in less than a year
The strategy of the prop firm is yielding results quickly. In November, the company was recognized as the best trading platform of the month by Forex Prop Review, surpassing more than 30 other firms in the sector. This accolade highlights the company’s commitment to quality, transparency, and operational security for its traders.
One of the milestones that strengthened Wall Street Funded reputation was its swift response to a crisis during its first month of operations. When MetaTrader revoked its licenses, leaving thousands of traders without a platform to operate, the company responded quickly, migrating accounts to cTrader and Dxtrade in record time. This rapid adaptation allowed WSFunded to position itself as one of the most efficient firms in integrating new platforms, reinforcing customer trust and consolidating its market position.
Ambitious plans: launching its own broker
Having successfully achieved its initial objectives, Wall Street Funded is now focused on its next major challenge: launching its own broker in 2025. This project aims to provide traders with more competitive conditions, including lower commissions and a rigorous selection of liquidity providers. Through this initiative, the company seeks to surpass current market offerings and create an ecosystem that supports and empowers traders, further strengthening its industry position.
WSFunded’s vision extends beyond becoming a standout firm in the sector. The company is driven by the ambition to establish itself as a leader, earning traders’ trust by demonstrating it is the best choice for them. This commitment, supported by the founders’ experience as former consumers of funding accounts, has enabled them to incorporate the best market practices and raise existing standards, offering a differentiated service tailored to the real needs of users.
With a clear strategy and a focus on excellence, Wall Street Funded positions itself as one of the firms with the greatest growth potential in the trading sector. Its ambitious goal for the coming years is to rank among the top 10 Prop Firms worldwide. The challenge now is to maintain momentum and continue delivering value to a growing community of traders.
A differentiated proposal: security, transparency, and expertise
In a saturated market, Wall Street Funded aims to stand out with a business model focused on security and transparency,Currently with 5 leading trading platforms. Its risk management desk, composed of financial and trading experts, ensures effective sector analysis and responsible operational management. The company places the highest priority on aspects such as legality, fiscal responsibility, and fair treatment of its clients, establishing itself as a reliable and professional option for traders.
With an impressive track record in less than a year, Wall Street Funded promises to continue revolutionizing the trading industry, proving that a trader-centric approach can make a difference in the competitive financial world.
Only time will tell if these aspirations come to fruition, but Wall Street Funded trajectory thus far suggests it is on the right path to revolutionize the trading industry.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
US Expansion for DSCSA: Juleb Helps Companies Achieve Compliance Before the Deadline and Avoid Fines
Doha, Qatar, 4th March 2025, ZEX PR WIRE, Web Summit Qatar sets the stage for big announcements, and this year, Juleb, the leading Track & Trace compliance solution in Saudi Arabia, is making waves. Known for its powerful and modular ERP tailored for the pharmaceutical sector, Juleb has officially unveiled its US expansion strategy, aiming to help companies achieve full DSCSA (Drug Supply Chain Security Act) compliance ahead of looming deadlines—while avoiding costly fines and operational risks.
Juleb: Pioneering Track & Trace Compliance in the GCC
Founded with a mission to streamline and digitize the pharmaceutical supply chain, Juleb has become a market leader in Saudi Arabia for Track & Trace compliance. Its AI-powered ERP platform provides end-to-end solutions designed to meet complex regulatory requirements while improving operational efficiency for manufacturers, re-packagers, wholesalers and pharmacy retailers.
Juleb’s modular approach allows businesses to tailor the ERP to specific operational needs, whether it’s enhancing inventory management, simplifying B2B sales, or ensuring full regulatory compliance. The system seamlessly integrates with existing ERPs and WMSs offers real-time visibility across the entire supply chain, making it the go-to solution for companies looking to optimize processes and reduce risks.
Currently, Many ERP and track-and-trace solutions implemented in the US pharmaceutical sector face interoperability issues, as well a massive operational slowdown due to additional required labor and reporting overhead. Juleb understands the frustration from these hurdles and solves both problems seamlessly. Juleb handles all the aggregation file formats from other software providers, so companies would gain peace of mind from knowing that compliance is achieved with precision and ease. While operationally, with the bolt-scanning and ERP integration, the roadblocks from manual labor and reporting overheads are transforming to significantly shorter and streamlined processes, embodying the promise of operational excellence.
Expanding into the US: Helping Businesses Navigate DSCSA Compliance
With the DSCSA deadlines fast approaching—May 27, 2025, for manufacturers and repackagers, August 27, 2025, for wholesalers, and November 27, 2025, for larger dispensers—US-based Pharmaceutical companies and accredited Drug Distributors are racing to align their operations with the new regulations.
Non-compliance comes with heavy penalties:
- Fines up to $500,000 for entities
- Individual fines of up to $250,000
- Suspension of licenses, product confiscations, and further civil penalties
Juleb’s expansion into the US market aims to help wholesalers, distributors, and manufacturers navigate these challenges. With its Track & Trace leadership in KSA and a proven track record of helping companies achieve compliance, Juleb is perfectly positioned to support US businesses in adapting to the DSCSA framework.
“A Global Vision for a Stronger Pharma Supply Chain”
“Web Summit Qatar is the ideal platform to announce our US expansion,” said Yousuf Jamjoom, CEO of Juleb. “Our mission has always been to empower the pharmaceutical supply chain through smart, scalable solutions. As DSCSA deadlines loom, we’re stepping in to ensure companies can focus on what matters—delivering quality medications—while we handle the complexities of compliance.”
Juleb’s US strategy includes:
- Targeting small-to-medium wholesalers for early DSCSA compliance
- Localized modules tailored for US regulatory requirements
- Dedicated support teams for onboarding and compliance audits
- AI-powered analytics for real-time compliance tracking
What Makes Juleb Different?
- Track & Trace Expertise: #1 in KSA, now bringing its leadership to the US market
- Modular ERP: Serving manufacturing, wholesale and retail with scalable solutions
- Real-Time Visibility: Advanced BI dashboards to support data-driven decision-making
- Fast Deployment: Helping businesses go from complex processes to streamlined operations in weeks
- Cost-Efficiency: Avoid heavy fines and reduce operational inefficiencies
Looking Ahead: Juleb’s Bigger Expansion Plans
While the US expansion is a major focus, Juleb has its sights set on broader global opportunities. With over 40 countries implementing Track & Trace regulations, Juleb aims to become a global leader in pharmaceutical supply chain solutions, helping companies comply with evolving regulatory frameworks while optimizing their operations.
The company is also investing in AI-powered tools, enhancing warehouse mobility solutions, and developing B2B sales force mobility features, fostering a more interconnected and efficient pharma supply chain to ensure their partners are future-ready and equipped to excel.
For more information, You can Visit our website- https://juleb.com/dscsa
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
HiFuture to Showcase “Futuristic Innovations” at MWC Barcelona 2025

Shenzhen, China — HiFuture, a global leader in smart wearable and audio devices, is set to showcase its latest innovations at MWC Barcelona 2025, reaffirming its commitment to delivering cutting-edge wearables and audio solutions. With a strong presence in over 70+ countries and availability in 6,000+ retail stores, HiFuture has consistently pushed the boundaries of design, technology, and user experience.
At MWC 2025, HiFuture will introduce a new era of smart wearables and immersive audio solutions, designed to seamlessly integrate into users’ lives. From advanced health tracking and AI-powered insights to immersive sound experiences, the brand is focused on redefining how people interact with technology daily.
A vision for smart living
HiFuture’s philosophy revolves around enhancing everyday experiences through intelligent design and innovation. The brand’s presence at MWC Barcelona 2025 will highlight its expertise in next-generation fitness wearables, high-performance audio devices, and AI-enhanced connectivity solutions. Whether it’s tracking fitness goals, optimizing health insights, or delivering an immersive audio experience, HiFuture’s latest line-up is built to empower users.
What to Expect from HiFuture at MWC 2025?
Next-gen smart wearables – HiFuture to showcase its latest advancements at the MWC 2025 in fitness tracking, AI-driven health monitoring, and seamless connectivity, designed to enhance active lifestyles. Products like ACTIVE smartwatch and Future Ring2 convince on how technology can seamlessly blend style and functionality.
Immersive audio experiences – Our ASCENDO speaker and FutureTour X wireless headphones promise high-fidelity sound, noise cancellation, and AI-powered audio enhancements, setting a new standard for portable and immersive listening.
AI-driven innovation – From personalized fitness coaching to smart noise cancellation and voice enhancement, HiFuture’s products integrate AI-powered intelligence technology like the newly introduced – Syntra AI for greater personalization and efficiency.
Engage with HiFuture at MWC Barcelona 2025
Attendees of MWC Barcelona 2025 are invited to visit HiFuture’s exhibition to experience these groundbreaking products first-hand. The event promises to be a convergence of technology enthusiasts, industry leaders, and innovators, with HiFuture poised to contribute significantly to the dialogue on the future of smart wearables and audio technology.
HiFuture’s showcase at MWC Barcelona 2025 exemplifies its mission to integrate advanced technology into daily life, offering products that are not only functional but also enhance the user’s lifestyle through thoughtful design and innovation.
About HiFuture Group
Headquartered in Shenzhen, China, HiFuture Group was founded in 2016 by Levin Liu (CO-Founder) and Jova Cho (Co-Founder & CPO) with a revolutionary vision of making a difference in smart wearable & wireless speakers in the consumer electronics industry. Our mission is to innovate smart hearables and smart wearable devices by implementing the latest and advanced technologies and offering the young generation an unprecedented way toward lifestyle.
Media Contact:
Company Name: HiFuture Group
Email: info@hifuturegroup.com
Website: https://www.hifuturegroup.com/
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
Press Release
Avio Health Launches World’s First Functional Medicine LLM for Emagene Life, Transforming Personalized Healthcare
Kuala Lumpur, Malaysia, 3rd Mar 2025, – Avio Health, a deep-tech company dedicated to advancing healthcare through data analytics and machine learning, today announced the launch of the world’s first Functional Medicine-based Large Language Model (LLM) developed exclusively for Emagene.Life. This breakthrough follows 18 months of intensive research and development, delivering a new standard in personalized healthcare.
Through sophisticated machine learning, Avio Health’s system rapidly analyzes and unifies patient blood biomarker data from around the globe. Clinicians can now go from manually interpreting labs for hours to receiving comprehensive analysis in just minutes. Emagene Life professionals report the platform significantly enhances patient care and preventive health focus, giving doctors, dieticians, and nutritionists more time to spend on meaningful interactions with patients.
“Avio Health’s mission is to harness technology to streamline medical workflows while elevating patient-centric care,” said Elvin Siew, Founder Avio Health.
“By partnering with Emagene Life, we’ve shown how Functional Medicine can be powered by advanced data analysis—ultimately delivering quicker, more precise insights that empower healthcare providers and their patients.”
Key Highlights
- Transformative Speed: Shaves hours off lab data interpretation by leveraging a cutting-edge Functional Medicine-based LLM.
- Global Data Integration: Unifies and standardizes worldwide blood biomarker results into a single, comprehensive view.
- Enhanced Clinical Focus: Allows medical professionals to dedicate more time to patient relationships and preventive care strategies.
- Holistic Support: Delivers advanced insights for dieticians, nutritionists, and specialists seeking to offer personalized supplement and lifestyle recommendations.
- Precise Personalized Care: Delivers targeted lifestyle interventions and supplement protocols based on each patient’s unique profile.
“As pioneers in functional medicine and preventative health, we are thrilled to integrate Avio Health’s advanced system,” added Dr Shirley Koeh, Medical Director Emagene Life.
“This tool not only saves clinicians significant time but also allows us to tailor medical advice more effectively—enhancing the overall patient experience.”
By accelerating lab analysis and boosting personalized recommendations, Avio Health and Emagene Life aim to redefine Functional Medicine in clinical practice.
For more information about Avio Health’s new LLM or to request a demonstration, please visit email info@avio.health
About Avio Health
Avio Health is a deep-tech company driving innovation in healthcare through advanced data analytics and machine learning. By developing intelligent solutions that streamline clinical workflows and optimize patient outcomes, Avio Health supports a broad spectrum of healthcare needs while delivering transformative results in specialized areas like Healthcare.
About Emagene Life
Emagene Life specializes in functional medicine and preventative health solutions designed to elevate patient well-being. By partnering with Avio Health, Emagene Life continues to expand its mission of delivering personalized healthcare through cutting-edge technology and expert clinical insight.
Media Contact:
Elvin Siew
60129799819
Media Contact
Organization: Avio Health
Contact
Person: Elvin Siew
Email:
elvin@avio.health
City: Kuala Lumpur
Country:Malaysia
The post Avio Health Launches World’s First Functional Medicine LLM for Emagene Life, Transforming Personalized Healthcare appeared first on
Brand News 24.
It is provided by a third-party content
provider. Brand News 24 makes no
warranties or representations in connection with it.
About Author
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.
-
Press Release7 days ago
KISED showcases support programs for global startups at MWC 2025’s 4YFN Event
-
Press Release7 days ago
The Steam Team Provides Comprehensive Restoration Services for Water and Fire Damage in Austin, TX
-
Press Release7 days ago
Minterest Launches adaptiFi: Its First Franchise Deployment on Morph L2
-
Press Release5 days ago
Ways 2 Wellness Partners with “The Senior Care Influencer” Lance A. Slatton to Expand Wellness Support for Caregivers and Families
-
Press Release4 days ago
ARise Just Killed Screens—See-Through Tech That Changes Everything
-
Press Release2 days ago
Blg Pro’s Major Upgrade: Exiting the Cryptocurrency Market to Focus on Forex and Commodity InvestmentsProviding Global Investors with More Stable Asset Allocation Solutions
-
Press Release5 days ago
Innovative Blockchain Lottery Platform, “LottoTether,” Officially Launched
-
Press Release4 days ago
ABA Therapy Can Transform Lives